Shares of online health platform Hims & Hers Health soared Tuesday after the company announced a partnership with Novo Nordisk to bring weight-loss drug Wegovy to its customers.

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...

Hims & Hers Health, Inc. teams up with Novo Nordisk to offer Wegovy at $599/month, slashing costs. Click for why this is a ...

Ozempic and similar weight loss drugs offer significant health benefits, including reduced heart disease risk and improved ...

SHOPPING: Take steps to achieve your body goals with Hers, the weight loss program that takes into account your specific ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

White House Director of Communications Steven Cheung blasted Joanna Coles for her "debilitating case of Trump Derangement Syndrome." ...

Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, ...

The company announced a long-term collaboration with Denmark-based Novo Nordisk A/S (NVO), which makes Wegovy and diabetes-treatment Ozempic, which are both approved by the Food and Drug ...

The drugmaker is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...

Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...